Cetinkaya, Erdem AtalayCiftci, OsmanAlan, SaadetOztanir, M. NamikBasak, Nese2024-08-042024-08-0420190385-81461879-1476https://doi.org/10.1016/j.anl.2018.07.005https://hdl.handle.net/11616/98400Objectives: In this experimental study, the effect of hesperidin on the treatment of acute otitis media (AOM) was investigated in an AOM-induced rat model. Methods: In total, 35 rats were randomly divided into the following five groups (n = 7): group 1 (control), group 2 (AOM with no treatment), group 3 (AOM + antibiotic), group 4 (AOM + hesperidin), and group 5 (AOM + hesperidin + antibiotic). On day 14, group 3,4 and 5 rats were given antibiotic and hesperidin via gavages, respectively. Histopathological and immunological analyses were performed and the results analyzed. Results: Serum levels of TNE-alpha, IL-4, IL-6 and IL-beta were significantly decreased in the hesperidin- and antibiotic-treated groups compared to the AOM group. The AOM + antibiotic and AOM + hesperidin groups demonstrated reduced histological damage compared to the AOM group. Between the AOM + antibiotic and AOM + hesperidin groups, significant differences in tympanic membrane thickness(ThicTM), inflammation(Inf), and sclerosis(Sc) values were observed. However, no difference in epithelial damage(DamEpith), was seen between the two groups. There was a significant difference in the AOM + antibiotic and AOM + antibiotic + hesperidin groups compared to AOM group (P < 0.001). Conclusions: In this study, we observed that both antibiotic and hesperidin treatment reduced AOM symptoms in an AOM-induced rat model. The values in AOM + antibiotic + hesperidin group were markedly lower than those of the other groups. From our results, we propose that hesperidin, in combination with antibiotics, may provide a successful alternative treatment for AOM compared with antibiotics used alone. (C) 2018 Elsevier B.V. All rights reserved.eninfo:eu-repo/semantics/closedAccessHesperidinAcute otitis mediaHistological examinationCytokinesRatsArticle4621721773007216210.1016/j.anl.2018.07.0052-s2.0-85050616669Q2WOS:000463846800004Q3